샘플 요청 목록

 카트 문의
시장보고서
상품코드
1766966

DNA 및 유전자 칩 시장

DNA and Gene Chip
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 371 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

DNA 및 유전자 칩 세계 시장은 2030년까지 205억 달러에 달할 전망

2024년에 114억 달러로 추정되는 DNA 및 유전자 칩 세계 시장은 2024년부터 2030년까지 CAGR 10.3%로 성장하여 2030년에는 205억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 소모품은 CAGR 10.2%를 기록하며 분석 기간 종료시에는 126억 달러에 달할 것으로 예측됩니다. 계측 기기 부문의 성장률은 분석 기간 동안 CAGR 10.5%로 추정됩니다.

미국 시장은 29억 달러, 중국은 CAGR 13.8%로 성장 예측

미국의 DNA 및 유전자 칩 시장은 2024년에 29억 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2030년까지 48억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 13.8%를 기록할 것으로 예상됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 6.7%와 8.5%로 예측됩니다. 유럽에서는 독일이 CAGR 7.8%로 성장할 것으로 예측됩니다.

세계의 DNA 및 유전자 칩 시장 - 주요 동향과 촉진요인 정리

DNA 및 유전자 칩은 유전자 조사와 진단에 어떤 혁명을 가져오고 있는가?

DNA 마이크로어레이로도 알려진 DNA 칩과 유전자 칩은 유전자 발현과 유전자 변이의 고처리량 분석을 가능하게함으로써 유전자 연구와 진단에 변화를 가져오고 있습니다. 이 칩은 고체 표면에 부착된 수천 개의 DNA 염기서열을 포함하고 있으며, 연구자들은 복잡한 유전 정보를 병렬로 분석하여 유전자 발현 패턴을 빠르게 파악할 수 있습니다. 이 기능은 유전적 돌연변이에 대한 이해가 맞춤의료 및 표적 치료제 개발에 필수적인 유전체, 약리유전체학, 종양학 등의 분야에 혁명을 일으켰으며, DNA 칩을 통해 의료진은 질병과 관련된 유전적 돌연변이를 식별하고 암, 심장병, 유전성 질환 등 암, 심장병, 유전성 질환 등의 증상에 대해 보다 정확한 진단과 맞춤형 치료를 유도할 수 있습니다.

임상 응용 외에도 DNA 칩과 유전자 칩은 신약 개발에서도 중요한 역할을 하고 있으며, 제약회사는 다양한 유전자가 약물 화합물에 어떻게 반응하는지를 연구할 수 있습니다. 이를 통해 잠재적 치료 표적의 식별을 가속화하고 개발 기간과 비용을 모두 줄일 수 있습니다. 농업 분야에서는 유전자 칩이 식물의 유전학 분석에 사용되어 작물의 수확량과 질병에 대한 저항력을 향상시키는 데 도움이 되고 있습니다. 맞춤형 의료에 대한 수요가 증가하고 유전자 연구가 발전함에 따라 DNA 칩과 유전자 칩은 다양한 과학 및 임상 분야에서 필수적인 도구가 되어 복잡한 유전자 데이터를 보다 빠르고 정확하게 분석할 수 있게 되었습니다.

어떤 기술 발전이 DNA 및 유전자 칩 시장을 형성하고 있는가?

바이오인포매틱스, 소형화, 고밀도 마이크로어레이의 혁신이 주도하고 있습니다. 생물정보학 도구를 통해 연구자들은 유전자 칩에서 생성된 방대한 양의 유전자 데이터를 분석하여 유전자 발현 패턴에 대한 인사이트를 얻고 특정 질병과 관련된 돌연변이를 식별할 수 있습니다. 이러한 도구는 유전체 전체 연관성 연구(GWAS)를 포함한 복잡한 분석을 지원하여 건강과 질병에 대한 유전적 영향에 대한 이해를 넓혀주었습니다. 소형화 및 고밀도 어레이의 발전으로 유전자 칩의 용량도 증가하여 하나의 칩에 수백만 개의 프로브를 탑재할 수 있게 되어 데이터 출력을 극대화하고 검사 정확도를 높일 수 있게 되었습니다.

또한, 차세대 염기서열 분석기(NGS)의 개발과 유전자 칩과의 통합으로 검출 가능한 유전자 변이 범위가 확대되고, 진단 정확도가 향상되어 맞춤형 치료 계획을 지원할 수 있게 되었으며, 랩온어칩 기술의 혁신은 유전자 칩의 사용 편의성을 더욱 향상시켜 임상 현장에서의 활용도를 더욱 높일 수 있습니다. 임상 현장에서의 활용을 더욱 친숙하게 만들고 있습니다. 이러한 발전으로 의료진은 진료 시점에 신속한 유전자 검사를 실시하여 중요한 질병에 대한 결과를 적시에 제공할 수 있게 되었습니다. 기술이 계속 발전함에 따라 DNA 및 유전자 칩은 더욱 강력하고, 저렴하고, 실용적이며, 더 큰 규모의 고정밀 유전자 분석을 이용할 수 있게 되었습니다.

왜 DNA 및 유전자 칩이 맞춤형 의료에 필수적인가?

DNA 및 유전자 칩은 종합적인 유전자 프로파일링을 가능하게 하여 의료진이 환자 개개인에게 맞춤화된 치료를 할 수 있게함으로써 맞춤형 의료에 필수적인 요소입니다. 유전자 칩은 유전자 발현 패턴을 분석하고 유전자 변이를 감지함으로써 환자가 특정 약물이나 치료에 어떻게 반응하는지에 대한 인사이트를 제공합니다. 예를 들어, 유전자 칩은 암 관련 유전자 변이를 식별할 수 있으며, 암 전문의는 환자별 유전자 프로파일을 기반으로 환자에게 가장 효과적인 표적 치료법을 선택할 수 있습니다. 이러한 개인화 접근 방식은 치료 결과를 개선하고 약물 부작용의 위험을 줄이며 환자의 안전과 치료의 질을 향상시킬 수 있습니다.

암 치료 외에도 유전자 칩은 심혈관질환, 당뇨병, 정신 질환을 포함한 다양한 증상에 대한 유전적 소인을 평가하는 데 사용됩니다. 이 정보를 통해 의료진은 개인별 위험 요인에 맞는 예방 치료 계획을 수립할 수 있고, 환자는 보다 효과적으로 건강을 관리할 수 있게 됩니다. 저렴한 비용으로 정확한 유전자 정보를 제공하는 유전자 칩의 능력으로 유전자 검사에 대한 접근성이 확대되어 더 많은 환자들에게 맞춤형 의료가 현실로 다가오고 있습니다. 개인화된 데이터 기반 의료에 대한 관심이 높아짐에 따라 DNA 및 유전자 칩은 개인별 유전자 프로파일에 맞는 맞춤형 치료를 제공하는 데 필수적인 도구가 되고 있습니다.

DNA 및 유전자 칩 시장의 성장 원동력은?

DNA 및 유전자 칩 시장의 성장은 맞춤형 의료에 대한 수요 증가, 유전체학 연구의 발전, 유전자 검사 기술에 대한 투자 증가 등 여러 가지 요인에 의해 이루어지고 있습니다. 헬스케어가 맞춤형 치료 접근법으로 나아가고 있는 가운데, DNA 및 유전자 칩은 정확한 유전자 분석을 가능하게 하고, 표적 치료를 지원하며, 예방 의료를 촉진하는 데 중요한 역할을 하고 있습니다. 생물정보학 및 차세대 염기서열 분석(NGS)의 급속한 발전은 유전자 칩의 기능을 보완하고 유전자 변이를 보다 정확하게 검출할 수 있게함으로써 시장을 더욱 촉진하고 있습니다.

유전체학 연구에 대한 자금 지원 증가, 헬스케어 및 제약 분야에서의 유전자 검사 도입 확대도 시장 확대에 기여하고 있습니다. 정부 및 민간 단체들은 질병의 유전적 요인을 더 잘 이해하기 위해 유전체학 프로젝트에 투자하고 있으며, 이는 연구 및 임상 분야에서 고처리량 DNA 칩에 대한 수요를 촉진하고 있습니다. 또한, 소비자들 사이에서 유전자 검사에 대한 인식이 높아지면서 소비자 직접 유전자 검사 서비스가 증가하고 있으며, 이는 시장 성장을 더욱 촉진하고 있습니다. 기술이 발전하고 헬스케어, 농업, 연구 분야에서 DNA 칩과 유전자 칩의 용도가 확대됨에 따라 시장은 지속적으로 성장하여 다양한 분야에서 혁신적이고 개인화된 솔루션을 지원할 것으로 예상됩니다.

부문

제품(소모품, 기기), 용도(암 진단·치료, 유전자 발현, 유전자 타이핑, Drug Discovery, 기타 용도), 최종 용도(학술·정부 연구기관, 병원·진단 센터, 바이오테크놀러지·제약 기업, 기타 최종 용도)

조사 대상 기업 사례

  • Affymetrix Inc
  • Agilent Technologies Inc.
  • Applied Microarrays Inc.
  • Arrayit Corp.
  • Biomerieux SA
  • Biometrix Technology Inc.
  • Bioneer Corp.
  • Canon Inc.
  • Capitalbio Corp.
  • Cytopathfinder Inc.
  • Eurofins Mwg Operon
  • Exiqon
  • Genisphere LLC
  • Greiner Bio-One
  • Hitachi Ltd.
  • Illumina Inc.
  • Integrated Dna Technologies
  • LC Sciences
  • Life Technologies Corp.
  • Lifegen Technologies
  • Macrogen Inc.
  • Microarrays Inc.
  • NGK Insulators Ltd.
  • Ocimum Biosolutions Ltd.
  • Oxford Gene Technology
  • Pamgene International B.V.
  • Perkinelmer
  • Promega Corp.
  • Roche Nimblegen Inc.
  • Samsung Electronics Co Ltd.
  • Savyon Diagnostics Ltd.
  • Scienion AG
  • Sequenom Inc.
  • Shanghai Biochip Co Ltd.
  • Sigma-Aldrich
  • Surmodics Inc.
  • Thermo Fisher Scientific Inc.
  • Toshiba Corp.
  • Wafergen Biosystems Inc.

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 일반적인 LLM 및 업계별 SLM 쿼리를 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

ksm 25.07.16

Global DNA and Gene Chip Market to Reach US$20.5 Billion by 2030

The global market for DNA and Gene Chip estimated at US$11.4 Billion in the year 2024, is expected to reach US$20.5 Billion by 2030, growing at a CAGR of 10.3% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 10.2% CAGR and reach US$12.6 Billion by the end of the analysis period. Growth in the Instrumentation segment is estimated at 10.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.9 Billion While China is Forecast to Grow at 13.8% CAGR

The DNA and Gene Chip market in the U.S. is estimated at US$2.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$4.8 Billion by the year 2030 trailing a CAGR of 13.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.7% and 8.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.8% CAGR.

Global DNA and Gene Chip Market - Key Trends & Drivers Summarized

How Are DNA and Gene Chips Revolutionizing Genetic Research and Diagnostics?

DNA and gene chips, also known as DNA microarrays, are transforming genetic research and diagnostics by enabling high-throughput analysis of gene expression and genetic mutations. These chips contain thousands of DNA sequences attached to a solid surface, allowing researchers to analyze complex genetic information in parallel and quickly identify patterns in gene expression. This capability has revolutionized fields like genomics, pharmacogenomics, and oncology, where understanding genetic variations is essential for developing personalized medicine and targeted therapies. With DNA chips, healthcare providers can identify genetic mutations linked to diseases, guiding more accurate diagnoses and customized treatments for conditions like cancer, heart disease, and hereditary disorders.

In addition to clinical applications, DNA and gene chips play a crucial role in drug discovery, enabling pharmaceutical companies to test how different genes react to drug compounds. This accelerates the identification of potential therapeutic targets, reducing both development time and costs. In agriculture, gene chips are used to analyze plant genetics, helping improve crop yields and resistance to disease. As demand for personalized medicine grows and genetic research advances, DNA and gene chips have become indispensable tools across a range of scientific and clinical fields, supporting faster, more precise analysis of complex genetic data.

What Technological Advancements Are Shaping the DNA and Gene Chip Market?

Technological advancements are significantly enhancing the capabilities and applications of DNA and gene chips, with innovations in bioinformatics, miniaturization, and high-density microarrays leading the way. Bioinformatics tools allow researchers to analyze vast amounts of genetic data generated by gene chips, providing insights into genetic expression patterns and identifying mutations linked to specific diseases. These tools support complex analyses, including genome-wide association studies (GWAS), which have broadened our understanding of genetic influences on health and disease. Miniaturization and advances in high-density arrays have also increased the capacity of gene chips, enabling them to house millions of probes on a single chip, thereby maximizing data output and improving test accuracy.

In addition, the development of next-generation sequencing (NGS) and integration with gene chips has expanded the range of detectable genetic variants, enhancing diagnostic accuracy and supporting personalized treatment planning. Innovations in lab-on-a-chip technology have further improved gene chip usability, making them more accessible in clinical settings. These advancements allow healthcare providers to conduct rapid genetic testing at the point of care, providing timely results for critical conditions. As technology continues to evolve, DNA and gene chips are becoming more powerful, affordable, and practical, making high-precision genetic analysis available on a larger scale.

Why Are DNA and Gene Chips Essential in Personalized Medicine?

DNA and gene chips are essential to personalized medicine because they allow for comprehensive genetic profiling, enabling healthcare providers to tailor treatments to individual patients. By analyzing gene expression patterns and detecting genetic mutations, gene chips provide insights into how a patient may respond to specific medications or treatments, which is particularly valuable in fields like oncology. For example, gene chips can identify mutations in cancer-related genes, guiding oncologists to select the most effective targeted therapies for patients based on their unique genetic profiles. This personalized approach improves treatment outcomes and reduces the risk of adverse drug reactions, enhancing patient safety and quality of care.

In addition to cancer treatment, gene chips are used to assess genetic predispositions to various conditions, including cardiovascular disease, diabetes, and mental health disorders. With this information, healthcare providers can create preventive care plans tailored to individual risk factors, helping patients manage their health more effectively. The ability of gene chips to provide precise genetic information at a lower cost has expanded access to genetic testing, bringing personalized medicine closer to reality for more patients. As the focus on personalized, data-driven healthcare grows, DNA and gene chips are becoming essential tools for delivering targeted, effective treatments that cater to individual genetic profiles.

What Is Driving Growth in the DNA and Gene Chip Market?

The growth in the DNA and gene chip market is driven by several factors, including the rising demand for personalized medicine, advancements in genomics research, and increased investment in genetic testing technology. As healthcare moves toward individualized treatment approaches, DNA and gene chips play a crucial role in enabling precise genetic analysis, supporting targeted therapies, and facilitating preventive care. The rapid advancement of bioinformatics and next-generation sequencing (NGS) has further propelled the market, as these technologies complement gene chip capabilities, allowing for more accurate detection of genetic variants.

Increased funding for genomics research and growing adoption of genetic testing in healthcare and pharmaceutical sectors are also contributing to market expansion. Governments and private organizations are investing in genomics projects to enhance understanding of genetic factors in disease, which drives demand for high-throughput DNA chips in research and clinical settings. Moreover, the growing awareness of genetic testing among consumers is leading to an increase in direct-to-consumer genetic testing services, further fueling market growth. As technology improves and applications for DNA and gene chips expand across healthcare, agriculture, and research, the market is expected to experience sustained growth, supporting innovative, personalized solutions in various fields.

SCOPE OF STUDY:

The report analyzes the DNA and Gene Chip market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Consumables, Instrumentation); Application (Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery, Other Applications); End-Use (Academic & Government Research Institutes, Hospitals & Diagnostic Centers, Biotech & Pharma Companies, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

  • Affymetrix Inc
  • Agilent Technologies Inc.
  • Applied Microarrays Inc.
  • Arrayit Corp.
  • Biomerieux SA
  • Biometrix Technology Inc.
  • Bioneer Corp.
  • Canon Inc.
  • Capitalbio Corp.
  • Cytopathfinder Inc.
  • Eurofins Mwg Operon
  • Exiqon
  • Genisphere LLC
  • Greiner Bio-One
  • Hitachi Ltd.
  • Illumina Inc.
  • Integrated Dna Technologies
  • LC Sciences
  • Life Technologies Corp.
  • Lifegen Technologies
  • Macrogen Inc.
  • Microarrays Inc.
  • NGK Insulators Ltd.
  • Ocimum Biosolutions Ltd.
  • Oxford Gene Technology
  • Pamgene International B.V.
  • Perkinelmer
  • Promega Corp.
  • Roche Nimblegen Inc.
  • Samsung Electronics Co Ltd.
  • Savyon Diagnostics Ltd.
  • Scienion AG
  • Sequenom Inc.
  • Shanghai Biochip Co Ltd.
  • Sigma-Aldrich
  • Surmodics Inc.
  • Thermo Fisher Scientific Inc.
  • Toshiba Corp.
  • Wafergen Biosystems Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • DNA and Gene Chip - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Demand for Genomic Research Drives Growth of DNA and Gene Chip Market in Personalized Medicine
    • Rising Prevalence of Genetic Disorders and Cancers Spurs Adoption of DNA and Gene Chips for Early Diagnosis
    • Advancements in Microarray Technology Improve Accuracy and Efficiency in DNA and Gene Chip Applications
    • Growing Focus on Personalized Medicine and Pharmacogenomics Enhances Demand for DNA and Gene Chips in Drug Development
    • Expansion of Precision Medicine Initiatives Globally Fuels Market for DNA and Gene Chips in Targeted Therapies
    • Increasing Application of DNA and Gene Chips in Oncology Research Expands Market for Cancer Diagnostics
    • Growth in Agricultural Biotechnology for Crop Improvement Drives Demand for DNA and Gene Chips in Agrigenomics
    • Emergence of Direct-to-Consumer Genetic Testing Increases Adoption of DNA and Gene Chips in Consumer Genomics
    • Rising Application of DNA and Gene Chips in Infectious Disease Research Expands Use in Pathogen Detection
    • Increased Focus on Biomarker Discovery in Research and Diagnostics Fuels Development of DNA and Gene Chip Solutions
    • Technological Advancements in Genomics and Bioinformatics Enhance Application and Accuracy of DNA and Gene Chips
    • Growing Role of DNA and Gene Chips in Neurogenetics for Early Diagnosis and Research in Neurological Disorders
    • Expansion of Next-Generation Sequencing (NGS) Capabilities Increases Use of DNA Chips in Genomic Analysis
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for DNA and Gene Chip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for DNA and Gene Chip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for DNA and Gene Chip by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Instrumentation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Instrumentation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Instrumentation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Biotech & Pharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Biotech & Pharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Biotech & Pharma Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Academic & Government Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Academic & Government Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Academic & Government Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Hospitals & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Hospitals & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Hospitals & Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Cancer Diagnosis & Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Cancer Diagnosis & Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for Cancer Diagnosis & Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Gene Expression by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Gene Expression by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 27: World 15-Year Perspective for Gene Expression by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Genotyping by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Genotyping by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 30: World 15-Year Perspective for Genotyping by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 33: World 15-Year Perspective for Drug Discovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 35: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 36: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 37: World DNA and Gene Chip Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • DNA and Gene Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • DNA and Gene Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • DNA and Gene Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • DNA and Gene Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for DNA and Gene Chip by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for DNA and Gene Chip by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for DNA and Gene Chip by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • DNA and Gene Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • DNA and Gene Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • DNA and Gene Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 122: Spain Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Spain 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 131: Russia Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Russia 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • DNA and Gene Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for DNA and Gene Chip by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for DNA and Gene Chip by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for DNA and Gene Chip by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • DNA and Gene Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 161: Australia Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Australia 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
  • INDIA
    • DNA and Gene Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 170: India Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: India 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: South Korea 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • DNA and Gene Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for DNA and Gene Chip by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for DNA and Gene Chip by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for DNA and Gene Chip by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Latin America 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Argentina 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Brazil 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Mexico 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • DNA and Gene Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for DNA and Gene Chip by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for DNA and Gene Chip by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for DNA and Gene Chip by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Middle East 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 257: Iran Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Iran 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 266: Israel Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Israel 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 284: UAE Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: UAE 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
  • AFRICA
    • DNA and Gene Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 302: Africa Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 310: Africa 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제